Welcome to LookChem.com Sign In|Join Free

CAS

  • or

885672-69-5

Post Buying Request

885672-69-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

885672-69-5 Usage

General Description

1-(4-chloro-phenyl)-N3,N3-dimethyl-propane-1,3-diamine is a chemical compound with the molecular formula C11H18ClN3. It is a diamine derivative, containing a chlorophenyl group and two N,N-dimethylpropyl substituents. 1-(4-CHLORO-PHENYL)-N3,N3-DIMETHYL-PROPANE-1,3-DIAMINE is commonly used in the synthesis of pharmaceuticals and organic compounds, particularly in the production of medications and biologically active molecules. It has applications in medicinal chemistry and drug development due to its potential as a building block for creating new compounds with therapeutic properties. Additionally, it may also be used in research and development of new materials and chemicals. Overall, 1-(4-chloro-phenyl)-N3,N3-dimethyl-propane-1,3-diamine is a versatile chemical with diverse applications in various fields.

Check Digit Verification of cas no

The CAS Registry Mumber 885672-69-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,5,6,7 and 2 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 885672-69:
(8*8)+(7*8)+(6*5)+(5*6)+(4*7)+(3*2)+(2*6)+(1*9)=235
235 % 10 = 5
So 885672-69-5 is a valid CAS Registry Number.

885672-69-5Relevant articles and documents

Discovery of 4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H- pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide (AZD5363), an orally bioavailable, potent inhibitor of Akt kinases

Addie, Matt,Ballard, Peter,Buttar, David,Crafter, Claire,Currie, Gordon,Davies, Barry R.,Debreczeni, Judit,Dry, Hannah,Dudley, Philippa,Greenwood, Ryan,Johnson, Paul D.,Kettle, Jason G.,Lane, Clare,Lamont, Gillian,Leach, Andrew,Luke, Richard W. A.,Morris, Jeff,Ogilvie, Donald,Page, Ken,Pass, Martin,Pearson, Stuart,Ruston, Linette

, p. 2059 - 2073 (2013/05/08)

Wide-ranging exploration of analogues of an ATP-competitive pyrrolopyrimidine inhibitor of Akt led to the discovery of clinical candidate AZD5363, which showed increased potency, reduced hERG affinity, and higher selectivity against the closely related AGC kinase ROCK. This compound demonstrated good preclinical drug metabolism and pharmacokinetics (DMPK) properties and, after oral dosing, showed pharmacodynamic knockdown of phosphorylation of Akt and downstream biomarkers in vivo, and inhibition of tumor growth in a breast cancer xenograft model.

Novel potent and efficacious nonpeptidic urotensin II receptor agonists

Lehmann, Fredrik,Pettersen, Anna,Currier, Erika A.,Sherbukhin, Vladimir,Olsson, Roger,Hacksell, Uli,Luthman, Kristina

, p. 2232 - 2240 (2007/10/03)

Six different series of nonpeptidic urotensin II receptor agonists have been synthesized and evaluated for their agonistic activity in a cell-based assay (R-SAT). The compounds are ring-opened analogues of the isochromanone-based agonist AC-7954 with different functionalities constituting the linker between the two aromatic ring moieties. Several of the compounds are highly potent and efficacious, with N-[1-(4-chlorophenyl)-3-(dimethylamino)- propyl]-4-phenylbenzamide oxalate (5d) being the most potent. The pure enantiomers of 5d were obtained from the corresponding diastereomeric amides. It was shown by a combination of X-ray crystallography and chemical correlation that the activity resides in the S-enantiomer of 5d (pEC50 7.49).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 885672-69-5